Literature DB >> 30968433

Removing melatonin receptor type 1 signaling leads to selective leptin resistance in the arcuate nucleus.

Daniella Buonfiglio1,2, Cynthia Tchio2, Isadora Furigo1, José Donato1, Kenkichi Baba2, José Cipolla-Neto1, Gianluca Tosini2.   

Abstract

Recent studies have highlighted the involvement of melatonin in the regulation of energy homeostasis. In this study, we report that mice lacking melatonin receptor 1 (MT1 KO) gained more weight, had a higher cumulative food intake, and were more hyperphagic after fasting compared to controls (WT). In response to a leptin injection, MT1 KO mice showed a diminished reduction in body weight and food intake. To evaluate hypothalamic leptin signaling, we tested leptin-induced phosphorylation of the signal transducer and activator of transcription 3 (STAT3). Leptin failed to induce STAT3 phosphorylation in MT1 KO mice beyond levels observed in mice injected with phosphate-buffered saline (PBS). Furthermore, STAT3 phosphorylation within the arcuate nucleus (ARH) was decreased in MT1 KO mice. Leptin receptor mRNA levels in the hypothalamus of MT1 KO were significantly reduced (about 50%) compared to WT. This study shows that: (a) MT1 deficiency causes weight gain and increased food intake; (b) a lack of MT1 signaling induces leptin resistance; (c) leptin resistance is ARH region-specific; and (d) leptin resistance is likely due to down-regulation of the leptin receptor. Our data demonstrate that MT1 signaling is an important modulator of leptin signaling.
© 2019 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  leptin receptor; leptin resistance; melatonin; melatonin receptor 1; metabolism; obesity

Year:  2019        PMID: 30968433      PMCID: PMC6687516          DOI: 10.1111/jpi.12580

Source DB:  PubMed          Journal:  J Pineal Res        ISSN: 0742-3098            Impact factor:   13.007


  9 in total

Review 1.  The Role of the Melatoninergic System in Circadian and Seasonal Rhythms-Insights From Different Mouse Strains.

Authors:  Martina Pfeffer; Charlotte von Gall; Helmut Wicht; Horst-Werner Korf
Journal:  Front Physiol       Date:  2022-04-12       Impact factor: 4.755

2.  Administration of Exogenous Melatonin Improves the Diurnal Rhythms of the Gut Microbiota in Mice Fed a High-Fat Diet.

Authors:  Jie Yin; Yuying Li; Hui Han; Jie Ma; Gang Liu; Xin Wu; Xingguo Huang; Rejun Fang; Kenkichi Baba; Peng Bin; Guoqiang Zhu; Wenkai Ren; Bie Tan; Gianluca Tosini; Xi He; Tiejun Li; Yulong Yin
Journal:  mSystems       Date:  2020-05-19       Impact factor: 6.496

3.  Removal of melatonin receptor type 1 signalling induces dyslipidaemia and hormonal changes in mice subjected to environmental circadian disruption.

Authors:  Cynthia Tchio; Kenkichi Baba; Giuseppe Piccione; Gianluca Tosini
Journal:  Endocrinol Diabetes Metab       Date:  2020-09-10

4.  NAD+-boosting therapy alleviates nonalcoholic fatty liver disease via stimulating a novel exerkine Fndc5/irisin.

Authors:  Dong-Jie Li; Si-Jia Sun; Jiang-Tao Fu; Shen-Xi Ouyang; Qin-Jie Zhao; Li Su; Qing-Xi Ji; Di-Ynag Sun; Jia-Hui Zhu; Guo-Yan Zhang; Jia-Wei Ma; Xiu-Ting Lan; Yi Zhao; Jie Tong; Guo-Qiang Li; Fu-Ming Shen; Pei Wang
Journal:  Theranostics       Date:  2021-02-25       Impact factor: 11.556

Review 5.  Mechanisms of Melatonin in Obesity: A Review.

Authors:  Qingyun Guan; Zixu Wang; Jing Cao; Yulan Dong; Yaoxing Chen
Journal:  Int J Mol Sci       Date:  2021-12-25       Impact factor: 5.923

Review 6.  The role of melatonin in the treatment of type 2 diabetes mellitus and Alzheimer's disease.

Authors:  Shengnan Shen; Qiwen Liao; Yin Kwan Wong; Xiao Chen; Chuanbin Yang; Chengchao Xu; Jichao Sun; Jigang Wang
Journal:  Int J Biol Sci       Date:  2022-01-01       Impact factor: 6.580

7.  Identification of Key Regions Mediating Human Melatonin Type 1 Receptor Functional Selectivity Revealed by Natural Variants.

Authors:  Alan Hegron; Eunna Huh; Xavier Deupi; Badr Sokrat; Wenwen Gao; Christian Le Gouill; Mickaël Canouil; Mathilde Boissel; Guillaume Charpentier; Ronan Roussel; Beverley Balkau; Philippe Froguel; Bianca Plouffe; Amélie Bonnefond; Olivier Lichtarge; Ralf Jockers; Michel Bouvier
Journal:  ACS Pharmacol Transl Sci       Date:  2021-09-01

8.  Therapeutic Target Analysis and Molecular Mechanism of Melatonin - Treated Leptin Resistance Induced Obesity: A Systematic Study of Network Pharmacology.

Authors:  Vennila Suriagandhi; Vasanthi Nachiappan
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-22       Impact factor: 6.055

9.  Metabolic and hormonal effects of melatonin and/or magnesium supplementation in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial.

Authors:  Mohammad Alizadeh; Majid Karandish; Mohammad Asghari Jafarabadi; Lida Heidari; Roshan Nikbakht; Hossein Babaahmadi Rezaei; Reihaneh Mousavi
Journal:  Nutr Metab (Lond)       Date:  2021-06-06       Impact factor: 4.169

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.